Cervical cancer is a disease in which cells in the cervix grow abnormally, escape normal control and may form a tumor. The cervix is the lower, narrow part of the uterus that opens into the vagina. Most cervical cancers are linked to persistent infection with high-risk human papillomavirus, especially HPV types that can disrupt normal cell-cycle control.
Cervical cancer describes malignant tumors that begin in the cells of the cervix. These tumors most often arise from squamous cells on the outer cervix or glandular cells in the cervical canal.
Cervical cancer occurs when cervical cells acquire changes that allow uncontrolled growth, survival, invasion and possible spread. In many cases, persistent infection with high-risk HPV drives early precancerous changes before invasive cancer develops.
The cervix sits at the lower end of the uterus and connects the uterus with the vagina.
Long-lasting infection with high-risk HPV is the major biological driver of most cervical cancers.
Many cervical cancers begin in the transformation zone where two cervical cell types meet.
These quick facts support educational search intent for cervical cancer, HPV, cervical dysplasia, transformation zone biology and cervical tumor types.
Long-lasting high-risk HPV infection can cause cervical cell changes that may progress to cancer over time.
Most cervical cancers are squamous cell carcinomas, often developing in the transformation zone.
Cervical cancer is strongly connected with prevention strategies such as HPV vaccination and cervical screening programs.
Cervical cancer is not one single disease. The main types differ by cell of origin, microscopic appearance, HPV biology, tumor behavior and treatment planning.
The most common cervical cancer type. It develops from thin, flat squamous cells, most often near the transformation zone.
Develops from glandular cells in the endocervix that produce mucus. It is less common than squamous cell carcinoma.
A mixed cervical cancer type with both squamous and glandular features.
Rare forms can include neuroendocrine, small cell, clear cell, sarcoma-like or other uncommon cervical tumor types.
Most HPV infections do not become cancer. Cervical cancer risk increases when high-risk HPV infection persists and causes long-term changes in cervical cells. NCI explains that long-lasting high-risk HPV infections can cause cancers in tissues where HPV infects cells, including the cervix. :contentReference[oaicite:1]{index=1}
High-risk HPV can infect cells in the cervix, especially in areas of active cell turnover.
Most HPV infections clear, but persistent high-risk infection is the major concern.
Cervical intraepithelial neoplasia describes abnormal cervical cell changes before invasive cancer.
If abnormal cells invade deeper cervical tissue, the disease is considered invasive cervical cancer.
Early cervical cancer may cause no symptoms. When symptoms occur, they may involve abnormal bleeding, discharge, pelvic pain or pain during sex.
Bleeding after sex, between periods or after menopause is a commonly discussed warning symptom.
Discharge that is watery, bloody, persistent or has a strong odor can be a reason for medical evaluation.
Persistent pelvic pain, lower abdominal discomfort or pain during intercourse may be reported in cervical cancer symptom lists.
Advanced disease may cause leg swelling, urinary symptoms, bowel symptoms, fatigue or weight loss.
Having a risk factor does not mean someone will develop cervical cancer. Many risk factors relate to persistent high-risk HPV infection or reduced ability to clear HPV.
Persistent high-risk HPV infection is the most important risk factor for cervical cancer.
Cervical screening can find precancerous changes before invasive cancer develops.
Smoking is a recognized cervical cancer risk factor and may affect local immune defense.
Reduced immune function may make it harder to clear HPV infection.
Cancer risk depends more on persistent high-risk HPV infection than on short-term HPV exposure.
Limited access to screening, vaccination or follow-up care can increase cervical cancer burden.
Cervical cancer biology includes HPV-driven cell-cycle disruption, transformation zone vulnerability, precancerous lesions, invasive growth, immune escape and tumor microenvironment changes.
The transformation zone is where squamous and glandular cervical cells meet and where many cervical cancers begin.
HPV oncogenic proteins are studied because they interfere with normal cell-cycle protection pathways.
Cervical intraepithelial neoplasia describes abnormal cervical cell changes that can precede cancer.
Immune surveillance helps clear HPV infections; persistent infection suggests viral and host factors are influencing cell survival.
These short explanations support search intent, voice search, educational snippets and clear indexing.
Cervical cancer starts in cells of the cervix, most often in the transformation zone between the exocervix and endocervix.
Most cervical cancers are linked to persistent infection with high-risk HPV, but not every HPV infection becomes cancer.
Cervical dysplasia means abnormal cervical cells. Some changes can regress, while higher-grade lesions may need clinical follow-up.
Cervical cancer is cancer that begins in the cervix, usually after long-lasting infection with high-risk HPV changes cervical cells over time.
Cervical cancer is a disease where cells in the cervix grow abnormally, form a tumor and may invade nearby tissue or spread to other body sites.
Squamous cell carcinoma is the most common cervical cancer type and often begins in the transformation zone.
Persistent infection with high-risk HPV can cause cervical cell changes that may progress from precancer to invasive cancer.
Clear answers to common cervical cancer questions.
Cervical cancer is cancer that starts in the cervix, the lower part of the uterus that connects to the vagina.
Most cervical cancers are linked to persistent infection with high-risk HPV.
The main types are squamous cell carcinoma and adenocarcinoma. Less common types include adenosquamous carcinoma and rare cervical tumors.
Yes. Early cervical cancer or precancer may cause no symptoms, which is why prevention and screening are important public-health tools.
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
Authoritative sources used to support this cervical cancer education page.